4Kataoka K, Kwon GS, Yokoyama M, et al. Block copolymer nanoparticles as vehicles for drug delivery [J]. J Controlled Release, 1993,24:119.
5Kwon GS, Kataoka K. Block copolymer nanoparticles as long-circulating drug vehicles [J].Adv Drug Delivery Rev,1995, 16:295.
6Kim JC, Lee EO, Kim JY, et al. Hemolytic and antifungal activity of liposome- entrapped amphotericin B prepared by the precipitation method[ J ] . Pharm Dev Technol , 1997,2:275.
7Bekersky I, Boswell GW, Piles R, et al. Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal Amphotericin B (AmBisome(R)): a 91-day study in rats [J] .Pharmaceut Res,2000,17:1494.
8Esposito E, Bortolotti F, Menegatti E. Amphiphihc association systems for Amphotericin B delivery[ J]. Int J Pharm,2003,260:249.
10Yoo HS, Lee KH, Oh JE, et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates[J]. J Controlled Release, 2000,68 ( 3 ): 419 - 431.
